MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/infdis/jiv056

Медицинская библиотека · The Journal of infectious diseases · 2015

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old.

Keitel Wendy A, Jackson Lisa A, Edupuganti Srilatha, Winokur Patricia L, Mulligan Mark J, Thornburg Natalie J, Patel Shital M, Rouphael Nadine G, Lai Lilin, Bangaru Sandhya, McNeal Monica M, Bellamy Abbie R, Hill Heather R, VTEU H3N2v Vaccine Study Work Group

СтатьяПоддержка NIH: внешняя программаПоддержка правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Variant influenza A(H3N2) viruses (H3N2v) have transmitted recently from pigs to humans in the United States. Vaccines strategies are needed.

METHODS

Healthy adults received 2 doses of subvirion H3N2v vaccine (15 µg of hemagglutinin/dose) 21 days apart in this open-label trial. Serum hemagglutination inhibition (HAI) and neutralizing (Neut) antibody (Ab) titers were measured before and 8 and 21 days after each dose. Memory B-cell (MBC) responses were assessed.

RESULTS

Vaccine was well tolerated. A total of 40% of subjects had an HAI Ab titer of ≥40 before vaccination. Eight-seven percent (95% confidence interval [CI], 79%-93%) and 73% (95% CI, 63%-81%) of subjects 18-64 years old (98 subjects) and ≥65 years old (90 subjects), respectively, had an HAI titer of ≥40 21 days after dose 1 (P = .01); 51% (95% CI, 41%-61%) and 52% (95% CI, 41%-62%) of younger and older subjects, respectively, developed ≥4-fold rises in titer (P = not significant). Neut Ab response patterns were similar. Geometric mean titers were higher in younger subjects. Dose 2 provided no significant enhancement in responses. Cross-reactive MBCs were detected before vaccination and expanded after vaccination. Preexisting H3N2v-specific MBCs positively correlated with early increases in vaccine-induced Ab.

CONCLUSIONS

In most healthy adults, one 15-µg dose of vaccine elicited levels of HAI Abs associated with protection. Studies in children and elderly individuals are indicated to define the immunization needs of these groups.

CLINICAL TRIALS REGISTRATION: NCT01746082.

Для цитирования: Keitel Wendy A, Jackson Lisa A, Edupuganti Srilatha, Winokur Patricia L, Mulligan Mark J, Thornburg Natalie J, Patel Shital M, Rouphael Nadine G, Lai Lilin, Bangaru Sandhya, McNeal Monica M, Bellamy Abbie R, Hill Heather R, VTEU H3N2v Vaccine Study Work Group. Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old.. The Journal of infectious diseases. 2015. DOI: 10.1093/infdis/jiv056.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.